Zenocutuzumab is a first-in-class bispecific antibody that binds to HER2 and HER3 receptors, thereby blocking the interaction of HER3 with its ligand neuregulin 1 (NRG1) or NRG1-fusion proteins.
A randomized controlled trial was performed to assess the safety and efficacy of primary precut sphincterotomy to access the bile duct during endoscopic retrograde cholangiopancreatography.
A team of investigators conducted a retrospective study to assess the use of indomethacin as prophylaxis of pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography.
Because primary pancreatic lymphoma is a rare disease, optimal diagnostic and therapeutic protocols have not yet been established.
SARS-CoV-2-associated pancreatitis may represent a distinct phenotype of pancreatitis characterized by metabolic stress, abdominal pain, and specific patterns of inflammation.
A group of researchers released a review describing indications of pancreatic cancer (PC) in the screening of high risk individuals.
PFS longer in pancreatic ductal adenocarcinoma with versus without homologous recombination deficiency
Post-approval study results on the risk of hyperinflation, acute pancreatitis, and death associated with the use of liquid-filled intragastric balloons have been made available by the FDA.
Mild pancreatic injury patterns were observed in a group of patients who were diagnosed with COVID-19 pneumonia, according to results published in Gastroenterology.
There are significant differences in the clinical features of early, late, and alcohol-related idiopathic chronic pancreatitis.
A team of investigators from China sought to assess the effect of sedation with intravenous lidocaine during endoscopic retrograde cholangiopancreatography (ERCP).
Receipt of molecularly matched therapy is associated with improved outcomes in patients with pancreatic cancer.
In the management of PNETs it is important to differentiate between functional and nonfunctional PNETs in order to determine the course of treatment.
A novel dual-hormone artificial pancreas system that delivers both rapid insulin and pramlintide was found to improve glucose control.
Natural genetic variants in a calcium-selective ion channel gene, TRPV6, appear to influence early-onset chronic pancreatitis.
Results of this study showed no improvement in the rate of 30-day hospital readmission for patients with cancer undergoing pancreatectomy between 2005 and 2011.
Chronic pancreatitis is associated with increased risk for diabetes-associated emergencies, including diabetic ketoacidosis.
The Food and Drug Administration has approved a new formulation of Pancreaze (pancrelipase; Vivus) Delayed Release Capsules which would allow for an extended shelf life of 36 months.
Promising results from an earlier-phase study of FOLFOX plus pegilodecakin in metastatic PDAC refractory to gemcitabine provided a rationale for this study.
Exceeding tolerances of healthy organs-at-risk as a result of daily anatomical deformations is a concern for patients with LAPC treated with SBRT.